Israeli Biotech CollPlant Opens U.S. Hub to Expand rhCollagen Distribution

Jerusalem, 27 October, 2025 (TPS-IL) — Israeli regenerative medicine company CollPlant Biotechnologies is expanding its North American footprint with a new U.S. logistics hub to distribute its recombinant human collagen (rhCollagen) and BioInk products. Set to become operational this quarter, the facility offers cGMP-compliant storage, clinical supply services, AI-powered security, and cloud-based temperature monitoring.

CEO Yehiel Tal said the hub “demonstrates our long-term commitment to the North American market” and will reduce shipping times while maintaining local inventory.